AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · United States

H.R. 8000

END 7-OH Act

Status

Pending

119th Congress (2025–2026)

Would schedule synthetic 7-OH; excludes 7-OH naturally contained in the kratom plant. Not a whole-leaf ban or enacted law.

IntroducedMar 19, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Type: Official legislature record
Substances: Kratom / 7-OH

Official text

Summary of official legislation

Would schedule synthetic 7-OH; excludes 7-OH naturally contained in the kratom plant. Not a whole-leaf ban or enacted law.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: congress.gov

Legislative history

March 19, 2026
Referred to House Energy and Commerce and Judiciary.

Loading bill…